Covid 19

COVID-19 Resources

The pandemic has affected nearly every aspect of our lives, but none as important as that of our health and well-being.  Health disparities that existed before have been greatly enhanced with the onset of COVID-19. At CHOICE/CPAA, we have spent the last two years addressing the concerns of our community, even as we have kept our own staff safe by working remotely.

Care Connect Program - Help When and Where You Need It

Quarantine & Isolation
Calculator (Q&I)

The CDC has provided a tool to help anyone in our region determine how long you need to isolate, quarantine, or take other steps to prevent spreading COVID-19.  Just click on the Get Started button to the right.

If you or someone you know needs some emergency assistance due to having tested positive for and/or experiencing COVID-19 symptoms, please contact our CareConnect Hotline at 1-800-525-0127. To learn more about our CareConnect program, click here.

Crowd with Masks

Vaccination Information

If you or someone you know is looking for vaccine clinic, click here.  The Washington State Department of Health provides updated information about vaccine clinics according to zip codes. CHOICE is currently partnering with medical agencies providing vaccination opportunities at community resource fairs around the region.  Follow our Facebook page for notices of these events or check our event calendar.

Children & Youth Vaccine Resources

Currently, only children 5 to 11 can safely receive the Pfizer vaccine for COVID-19.

Vaccine manufacturers are conducting clinical trials to assess the safety and efficacy of COVID-19 vaccination among children younger than 5 years old. Pfizer-BioNTech has begun submitting data on a three-dose primary series to FDA for an Emergency Use Authorization (EUA) application for a vaccine for children ages 6 months through 4 years. Moderna has also begun submitting data on a two-dose primary series for children aged 6 months through 5 years. The U.S. Food and Drug Administration (FDA) will review the submitted data and determine if vaccines are safe and effective and if they should be authorized for emergency use.  Following FDA authorization, CDC’s Advisory Committee on Immunization Practices (ACIP) will meet to discuss making a recommendation to the CDC director on the use of authorized vaccines based on a thorough review of the available evidence. ACIP’s decision will be sent to the CDC director for review and the CDC director makes a final determination about the use of vaccine.  If the CDC director recommends use of the vaccine, it will become available for administration.

Here is a resource for both practitioners and parents to better understand what Pfizer-BioNTech and Moderna are currently planning for a possible emergency rollout, with the FDA's approval, of a vaccine.

June 15, 2022 - FDA Approves Vaccine for Children under 5

The FDA just announced the approval of the Pfizer and Moderna pediatric vaccines for children under age 5 for emergency use.  For more information, check out the Talking Points in English and Spanish.

In the window below, click on any of the topics and you will be redirected to the CDC website for more up-to-date information on a variety of Coronavirus health issues.